BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31674105)

  • 41. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
    Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
    JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
    Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
    Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The utility of PET/CT in the management of patients with colorectal liver metastases undergoing laparascopic radiofrequency thermal ablation.
    Sahin DA; Agcaoglu O; Chretien C; Siperstein A; Berber E
    Ann Surg Oncol; 2012 Mar; 19(3):850-5. PubMed ID: 21913009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant.
    Haberal M; Akdur A; Moray G; Arslan G; Özçay F; Selçuk H; Özdemir H
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):55-58. PubMed ID: 28302000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
    Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
    Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
    Rahmim A; Bak-Fredslund KP; Ashrafinia S; Lu L; Schmidtlein CR; Subramaniam RM; Morsing A; Keiding S; Horsager J; Munk OL
    Eur J Radiol; 2019 Apr; 113():101-109. PubMed ID: 30927933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reassessing the role of liver transplantation for patients with metastatic colorectal cancer to the liver.
    Chotai P; Matsuoka L
    Curr Opin Organ Transplant; 2019 Apr; 24(2):118-120. PubMed ID: 30694992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanding indications for laparoscopic parenchyma-sparing resection of posterosuperior liver segments in patients with colorectal metastases: comparison with open hepatectomy for immediate and long-term outcomes.
    Efanov M; Granov D; Alikhanov R; Rutkin I; Tsvirkun V; Kazakov I; Vankovich A; Koroleva A; Kovalenko D
    Surg Endosc; 2021 Jan; 35(1):96-103. PubMed ID: 31932927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete Metabolic Response on Interim
    Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
    Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation for colorectal liver metastases: revisiting the concept.
    Foss A; Adam R; Dueland S
    Transpl Int; 2010 Jul; 23(7):679-85. PubMed ID: 20477993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients With Indeterminate Extrahepatic Disease on 18FDG-PET Scan Before Liver Resection for Metastatic Colorectal Cancer.
    Wong GYM; Kumar R; Beeke C; Ullah S; Chen J; Karapetis C; Price T; Padbury R
    Ann Surg; 2018 May; 267(5):929-935. PubMed ID: 28169837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.
    Ma B; King AD; Leung L; Wang K; Poon A; Ho WM; Mo F; Chan CML; Chan ATC; Wong SCC
    Ann Oncol; 2017 Jul; 28(7):1576-1581. PubMed ID: 28379285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of Patients With Colorectal Liver Metastasis in the Developing World: Is Liver Transplantation for Unresectable Liver Metastasis, the Next Logical Step?
    M J; Kazi M; Patkar S; S PR; Bhoyar A; Desouza A; Saklani A; Goel M
    J Clin Exp Hepatol; 2023; 13(5):753-759. PubMed ID: 37693265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma.
    Unek T; Karademir S; Arslan NC; Egeli T; Atasoy G; Sagol O; Obuz F; Akarsu M; Astarcioglu I
    World J Gastroenterol; 2011 Oct; 17(37):4206-12. PubMed ID: 22072852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt.
    Kamel R; Hatata Y; Hosny K; Nabil A; El-Deen Abd-Allah A; Mostafa A; Abdel-Aal A; Elganzoury MZ; Elmalt O; Marwan I; Hosny A
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):12-20. PubMed ID: 28301993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
    Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
    Fernandez FG; Drebin JA; Linehan DC; Dehdashti F; Siegel BA; Strasberg SM
    Ann Surg; 2004 Sep; 240(3):438-47; discussion 447-50. PubMed ID: 15319715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
    Lanari J; Hagness M; Sartori A; Rosso E; Gringeri E; Dueland S; Cillo U; Line PD
    Transpl Int; 2021 Sep; 34(9):1722-1732. PubMed ID: 34448271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.
    van Dam RM; Lodewick TM; van den Broek MA; de Jong MC; Greve JW; Jansen RL; Bemelmans MH; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2014 Jun; 16(6):550-9. PubMed ID: 24246003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary nodules in liver transplant candidates with hepatocellular carcinoma: Imaging characteristics and clinical outcomes.
    Lee C; Ihde L; Kim A; Santos I; Matsuoka L; Cen Y; Wallman M; Grant E
    Liver Transpl; 2015 Sep; 21(9):1169-78. PubMed ID: 25845578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.